Beijing Tiantan Biological Products Corporation Limited’s Net Profit Rose 8.2% in First Half of 2022

Beijing Tiantan Biological Products Corporation Limited (北京天坛生物制品股份有限公司) (600161.SH) reported a net profit of 529.3 million yuan in the first half of 2022, up 8.2% year-on-year.

Meanwhile, the company posted 1.9 billion yuan in revenue, up 4.4% year-on-year.

At the end of the reporting period, it had 12.3 billion yuan in total assets and 1.6 billion yuan in total liabilities, with a liability-to-asset ratio of 13.1%.